InsiderSignal.AI

InsiderSignal.ai

ONCY - Oncolytics Biotech Inc

Insider Purchase by Pisano Wayne (Dir)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

1 week ago, Pisano Wayne, serving as Dir at Oncolytics Biotech Inc (ONCY), purchased 30,000 shares at $0.84 per share, for a total transaction value of $25,338.00. Following this transaction, Pisano Wayne now holds 492,414 shares of ONCY.

This purchase represents a 6.00% increase in Pisano Wayne's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, February 12, 2026 and publicly disclosed via SEC Form 4 filing on Friday, February 13, 2026, 1 day after the trade was made.

Oncolytics Biotech Inc operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.

Pisano Wayne

Pisano Wayne

Dir

Wayne Pisano is a seasoned biotechnology executive serving as Chair of the Board of Directors at Oncolytics Biotech Inc. (ONCY), a clinical-stage company developing pelareorep, an oncolytic viral immunotherapy for cancer treatment.[[1]](https://www.prnewswire.com/news-releases/oncolytics-biotech-names-new-ceo-to-accelerate-momentum-in-immunotherapy-programs-302478848.html)[[2]](https://www.marketbeat.com/instant-alerts/oncolytics-biotech-nasdaqoncy-director-wayne-pisano-buys-30000-shares-2026-02-13/)[[4]](https://oncolyticsbiotech.com/about-us/) He recently acted as Interim CEO before the appointment of Jared Kelly as CEO in June 2025, and on February 12, 2026, he purchased 30,000 shares at $0.84 each, increasing his holdings to 492,414 shares.[[1]](https://www.prnewswire.com/news-releases/oncolytics-biotech-names-new-ceo-to-accelerate-momentum-in-immunotherapy-programs-302478848.html)[[2]](https://www.marketbeat.com/instant-alerts/oncolytics-biotech-nasdaqoncy-director-wayne-pisano-buys-30000-shares-2026-02-13/)[[6]](https://www.stocktitan.net/sec-filings/ONCY/form-4-oncolytics-biotech-inc-insider-trading-activity-b0afbfede813.html) Pisano brings extensive experience in vaccines and biotech leadership, including roles as President and CEO of Sanofi Pasteur (2007–2011) and VaxInnate Corporation (2012–2016).[[3]](https://fintool.com/app/research/companies/ALT/people/wayne-pisano) He has served on the boards of multiple biopharma companies, such as Altimmune (ALT) since 2018, Provention Bio (until 2023), and IMV Inc. (until 2021), and holds directorships at Chattem, Inc. and River Acquisition Corp.[[3]](https://fintool.com/app/research/companies/ALT/people/wayne-pisano)[[5]](https://www.marketscreener.com/insider/WAYNE-PISANO-A0CN49/) Pisano earned a B.S. in Biology from St. John Fisher College and an MBA from the University of Dayton.[[3]](https://fintool.com/app/research/companies/ALT/people/wayne-pisano)

View full insider profile →

Trade Price

$0.84

Quantity

30,000

Total Value

$25,338.00

Shares Owned

492,414

Trade Date

Thursday, February 12, 2026

10 days ago

SEC Filing Date

Friday, February 13, 2026

Filed 1 day after trade

HEALTHCAREBIOTECHNOLOGY

About Oncolytics Biotech Inc

Company Overview

No company information available
View news mentioning ONCY

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/3943853

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime